Dermata Therapeutics Highlights Media Recognition of Tome Skincare Following Commercial Launch
- Tome Skincare featured in Cosmopolitan, Women's Wear Daily, AIR MAIL, and Thingtesting highlights Tome's growing recognition among leading beauty...
- Tome Skincare featured in Cosmopolitan, Women's Wear Daily, AIR MAIL, and Thingtesting highlights Tome's growing recognition among leading beauty...
Xycota's lead program aims to deliver clinical benefit from low-dose psilocybin without hallucinogenic effects, with mild PTSD as its initial...
New order-processing line: automated handling cell and roller conveyor now being commissioned at CosmoFarm's distribution center in Peristeri, Athens, designed...
Tony Pullen steps down from the Board and will continue with the Company as an advisorVancouver, British Columbia--(Newsfile Corp. -...
Vancouver, British Columbia--(Newsfile Corp. - November 5, 2026) - Apptly Health Technologies Corp. (CSE: APPT) (OTCQB: APTHF) (the "Company" or...
Completion of key IND-enabling activities represents a major development milestone for LB001IND submission remains on track for Q1 2027, followed...
CORK, Ireland, Nov. 05, 2026 (GLOBE NEWSWIRE) -- ArrayPatch Ltd (“ArrayPatch”), a biotech company developing innovative microneedle-based therapeutics, today announced...
Alethio Therapeutics Rohit Batta, CEO Series A financing co-led by Sofinnova Partners and RA Capital alongside founding investor Oxford Science...
40-fold lower virus load compared to placebo on Day 2, at the peak of viral replicationExposure-response relationship observed, with greater...
COPENHAGEN, Denmark – November 5, 2026. Novonesis delivered strong Q3 sales leading to 9M financial results at 7% organic sales...
$133 million Series B financing co-led by new investors Advent Life Sciences and British Business Bank, with additional new investments...
Strong Q3 sales leading to 9M at 7% organic sales growth and adj. EBITDA margin of 37.9%. 2026 outlook confirmed:...
Egetis Therapeutics’ lead asset, EMCITATE®, is the first and only approved treatment in U.S. and Europe for peripheral thyrotoxicosis associated...
Siemens Healthineers announced today it has initiated the carve-out process for its in vitro diagnostics business Olyrian Diagnostics Siemens Healthineers...
Vivoryon Therapeutics N.V. Reports Q3 2026 Financial Results and Provides Business Update Ongoing negotiations with different parties towards securing a partnership...
Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Q3 2026 Update: Tecan reports acceleration...
The project in Assam marks an important milestone in expanding access to advanced cancer care in India Louvain-La-Neuve, Belgium, November...
Oslo, 5 November 2026 – Zelluna (OSE: ZLNA), a clinical-stage company pioneering allogeneic "off-the-shelf" T Cell Receptor-based Natural Killer (TCR-NK)...
Highlights The Enterprise division delivered organic revenue growth of 1%, following positive market reception of the second wave of the...
Both doses of CBT-001 demonstrated statistically significant improvements in conjunctival hyperemia at Month 3 versus vehicle (p Both doses also...